Cultivated momordica species and extract thereof

Information

  • Patent Grant
  • 8071844
  • Patent Number
    8,071,844
  • Date Filed
    Monday, September 15, 2008
    16 years ago
  • Date Issued
    Tuesday, December 6, 2011
    13 years ago
Abstract
A plant grown from seeds derived from a new interhybrid of three plants of the Momordica genus has been cultivated. The new plant hybrid has a faster growth rate than the parent species. Parts of the new interhybrid plant which, when ingested by an individual, have blood glucose and/or insulin regulating properties. Foods and/or beverages containing parts or extracts of the new interhybrid plant and which to promote weight control or loss and/or blood glucose regulation are also disclosed.
Description
FIELD OF THE INVENTION

The present invention relates to a new plant hybrid of the genus Momordica, and, more particularly, to a new Momordica interhybrid, parts of which can be extracted to produce a material having improved blood sugar and/or insulin regulatory properties in humans.


BACKGROUND

Blood glucose levels play an important role in a person's energy levels and, in general, all bodily functions. A continuous excess of glucose in a person's blood stream is often an indicator of weight and/or blood glucose regulation issues. Generally, an individual's blood glucose levels should fall between about 70 to about 110 mg/ml.


Elevated blood glucose levels (i.e., greater than about 110 mg/dl) typically triggered by alimentary habits, can have a severe impact on an individual's health and can lead to a wide range of problems. For example, diabetes, heart disease, stroke, high blood pressure and blindness are some of the complications that can be derived from prolonged high blood glucose levels. Diabetes, in particular, has been shown to be a precursor of kidney and nervous system disorders and can also cause dental disease and complications of pregnancy.


Blood sugar imbalances attributable to diabetes are typically treated or controlled using insulin or insulin mimetics. For patients who are pre-diabetic and/or are non-insulin dependant, other forms of treatment or intervention may be employed to control blood glucose levels. For example, lifestyle changes that include weight management, nutritional control and/or counseling, and/or exercise regimens may be prescribed or recommended.


However, there is a need and a desire for a product, such as a natural product, that is effective for lowering blood glucose levels. Further, there is a need and a desire for an over-the-counter (OTC) product that can be utilized alone or in combination with other rehabilitative therapies to control blood glucose levels. There is an additional need and a desire for a natural product that can be used to supplement diet and exercise and/or promotes weight loss or control.


In another aspect, a product that is useful for controlling blood glucose and/or insulin levels can be advantageously included in foods and/or beverages used before, during and/or after exercise to maintain steady energy levels and/or hydration. For example, there is a need and a desire for a product or ingredient which promotes the maintenance of steady blood glucose levels that can be used in a sports drink, gel or energy-type food product.


Sports drink formulations generally fall into one of three categories. Isotonic sports drinks are generally designed to help athletes rehydrate as well as to maintain and/or replenish electrolytes such as, for example, sodium, potassium, calcium and magnesium, and other nutrients which can be depleted during strenuous activities. Some isotonic sports drinks may also include carbohydrates such as glucose for energy replenishment.


Another group of sports drinks includes carbohydrate-rich energy drinks. These drinks are specifically designed for use by physically active individuals and are primarily used shortly before or after exercise to boost muscle glycogen stores and help optimize sporting performance. Carbohydrates used in such energy sports drinks are typically derived from sucrose, fructose, glucose polymers, maltodextrin and/or polylactate. Energy sports drinks are less about replacing lost fluid and more about keeping the working muscles supplied with energy during very long and sustained workouts. The disadvantage of energy sports drinks is that their high carbohydrate concentrations tend to slow down the rate of water absorption, particularly during hard exercise.


Recovery sports drinks fall into the third category. Recovery sports drinks are generally taken after exercise and typically include water, carbohydrate and amino acids. Recovery sports drinks may include additional nutrients as electrolytes, minerals, vitamins needed to aid metabolism of the ingested carbohydrate, and protein to promote muscle recovery.


Generally, each of the above sports drinks is designed to provide a particular effect or benefit depending upon the activity an individual is engaged in or the point at which the beverage is ingested, i.e., rehydration during and after strenuous activities where electrolyte loss via perspiration is a concern; energy replenishment during prolonged physical activity; and post-activity muscle recovery. Currently, a sports drink formulation which addresses all three desired benefits, that is rehydration, energy replenishment and muscle recovery support, is not believed to be commercially available. Further, current commercially available sports drinks have not been designed to manage or maintain blood glucose and/or insulin levels, thereby providing an athlete with a steady level of energy throughout a workout or competition


In view of the above, there is a need and a demand for a sports drink formulation capable of providing rehydration, energy replenishment, and muscle recovery support in a single formulation. There is further need and a demand for a sports drink formulation having blood sugar and/or insulin regulatory properties.


SUMMARY

A general object of the invention is to provide a naturally-derived product which exhibits blood sugar and/or insulin regulation properties.


The general object of the invention can be obtained, at least in part, through a new plant hybrid of the genus Momordica and an extract derived there from. The new Momordica interhybrid extract is believed to control or regulate blood sugar and/or insulin levels within the body.


The invention further comprehends a food or beverage product containing the extract derived from the new plant hybrid that assists in the regulation of blood glucose and/or levels and can be utilized to promote weight loss or weight control. One such food or beverage product includes a sports drink which provides a three-fold benefit of rehydration, energy replenishment, and muscle recovery support in a single formulation. A further objective of the invention is to provide a sports drink having blood sugar and/or regulatory properties.


The sports drink formulation can include or consist of:


a carbohydrate source;


an amino acid blend;


a pyruvate blend;


a mineral blend;


a Momordica sp. extract;


one or more vitamins; and


one or more electrolytes.


Other objects and advantages will be apparent to those skilled in the art from the following detailed description taken in conjunction with the examples.







DETAILED DESCRIPTION

The invention provides a sports drink formulation which includes an extract of a newly derived plant hybrid of the genus Momordica. The Momordica sp. extract and the sports drink formulation including the Momordica sp. extract possess blood sugar and/or insulin regulation properties.


Extracts obtained from certain species of the Momordica genus have been shown to have a regulatory impact upon blood glucose and/or insulin levels in human subjects. In some cases it is believed that such extracts can successfully restore Beta cells' ability to secrete insulin. In the present invention, a new interhybrid of the genus Momordica has been cultivated to have an improved growth rate thereby providing an economical and readily accessible supply of plant material.


The newly derived plant hybrid of the genus Momordica (hereinafter the “McB interhybrid”) has been stabilized and asexually reproduced. The McB interhybrid is an interhybrid derived from a cross of Momordica charantia, commonly known as bitter melon, Momordica balsamina, and a previously unnamed Momordica species native to Ecuador. In particular, the McB interhybrid is a tetra-cross pollinated hybrid plant of the aforementioned Momordica species.


The McB interhybrid typically produces a seed having a zebra-like striped appearance versus the creamy white, dark brown or spotted seeds of the parent Momordica sp. The McB interhybrid further produces a rounded fruit as opposed to the typically elongated fruit of the parents, and has a larger leaf size. Additionally, the McB interhybrid has a faster growth rate than the parent Momordica sp.


In one aspect, the McB interhybrid can be derived from a tetra-cross pollination of the three parent Momordica species. For example, Species 1 is bred with Species 2 to create Hybrid 1 (H1). Species 1 is also bred with Species 3 to create Hybrid 2 (H2). H1 is crossed with H2 to create Hybrid 3 (H3). Thereafter, H1 is crossed with H3 to derive the new plant hybrid.


An extract of the McB interhybrid may be obtained via extraction of the plant material in a ratio of about 1 gram plant material to about 10 grams of extraction liquid. Typically, such extraction liquid may consist of or include, water, ethanol or a combination thereof. One suitable technique for obtaining a McB extract includes an aqueous soxhlet extraction method.


The sports drink formulation consists of or includes a carbohydrate source, an amino acid blend, a pyruvate blend, a mineral blend, the McB extract, vitamins and/or electrolytes.


The carbohydrate source can be derived from any carbohydrates typically employed in beverages. Such carbohydrate source suitably includes and/or consists of a sugar selected from the group consisting of sucrose, fructose, glucose polymers, maltodextrin, polylactate and combinations thereof. Suitably, the carbohydrate source includes or consists of about 80% to about 95% by weight sugar.


The amino acid blend suitably includes or consists of a branched chain formulation of essential amino acids selected from the group consisting of histidine, isoleucine, leucine, lysine, methionine, phenylalanine, theonine, tryptophan, valine, and combinations thereof.


One suitable amino acid blend includes or consists of:


















Histidine
 3.9%



Isoleucine
14.1%



Leucine
20.2%



Lysine
12.6%



Methionine
12.4%



Phenylalanine
12.0%



Threonine
 7.1%



Tryptophan
 3.9%



Valine
13.8%










The pyruvate blend suitably includes or consists of water soluble calcium pyruvate and sodium pyruvate. Suitably, such pyruvate blend can include or consist of calcium pyruvate blended with sodium pyruvate in a 50:50 ratio.


The mineral blend includes or consists of a combination of macro minerals, essential trace minerals and/or ultra trace minerals. Such macro minerals include or consist of Calcium, Carbon, Chloride, Magnesium, Phosphorus, Potassium, Sodium, Sulfur, and combinations thereof.


Such essential trace minerals include or consist of Chromium, Cobalt, Copper, Iodine, Iron, Manganese, Molybdenum, Selenium, Zinc, and combinations thereof.


Such ultra trace minerals include or consist of Aluminum, Antimony, Arsenic, Barium, Beryllium, Bismuth, Boron, Bromine, Cadmium, Cerium, Cesium, Cobalt, Dysprosium, Erbium, Europium, Fluorine, Gadolinium, Gallium, Germanium, Gold, Hafnium, Holmium, Hydrogen, Indium, Lanthanum, Lead, Lithium, Lutetium, Neodymium, Nickel, Niobium, Nitrogen, Osmium, Oxygen, Palladium, Platinum, Praseodymium, Rhenium, Rhodium, Rubidium, Ruthenium, Samarium, Scandium, Silicon, Silver, Strontium, Tantalum, Tellurium, Terbium, Thallium, Thorium, Thulium, Tin, Titanium, Tungsten, Vanadium, Ytterbium, Yttrium, Zirconium, and combinations thereof.


Vitamins which may be included in the sports drink include and/or consist of vitamin C, vitamin B3, vitamin B6, vitamin B12, and combinations thereof.


Electrolytes which may be included in the sports drink formulation include sodium, potassium and combinations thereof. Suitably the sports drink formulation includes or contains sodium in combination with potassium as potassium chloride. Other electrolytes may also be used in the sports drink formulation.


In accordance with one embodiment of the invention, a sports drink formulation having blood sugar and/or insulin regulatory properties includes and/or consists of about 75% to about 90% by weight carbohydrates, about 5% to about 20% by weight amino acids, and about 1% to about 5% by weight of the pyruvate blend, mineral blend, McB extract, vitamins and electrolytes.


The invention may be further understood in connection with the following Example.


EXAMPLE

A sports drink having blood sugar and/or insulin regulatory properties was prepared according to the formulation in TABLE 1. The sports drink provided, in an 8 ounce serving, 85 calories derived from 21 grams of total carbohydrates.












TABLE 1







Ingredient
Weight




















Sugar
20
g



Amino Acid Blend
2.5
g



Pyruvate blend
50
mg



Mineral Blend
2.5
mg



McB Extract
150
mg



Vitamin B3
50
mg



Vitamin B6
2.5
mg



Vitamin B12
0.50
mg



Vitamin C
30
mg



Calcium
25
mg



Zinc
0.25
mg



Sodium
10
mg



Potassium chloride
15
mg










The amino acid blend is disclosed above in paragraph [0017]. The pyruvate blend is a water soluble blend of calcium and sodium pyruvate in a 50:50 ratio. The mineral blend includes all of the macro minerals, essential trace minerals and ultra trace minerals disclosed above in paragraphs [0019]-[0021]. The McB extract was obtained via aqueous soxhlet extraction of the McB sp. plant material in a ratio of 1 gram plant material per 10 grams water.


While in the foregoing specification this invention has been described in relation to certain embodiments thereof, and many details have been put forth for the purpose of illustration, it will be apparent to those skilled in the art that the invention is susceptible to additional embodiments and that certain of the details described herein can be varied considerably without departing from the basic principles of the invention.


The McB interhybrid seeds of Momordica, producing the newly derived plant hybrid and used in the methods disclosed herein were deposited in a quantity of 2500 seeds with the American Type Culture Collection (ATCC®), Patent Depository, 10801 University Boulevard, Manassas, Va. 20110, on Apr. 21, 2011, tested and found to be viable on Jun. 2, 2011, and were accepted on Jun. 3, 2011 and have been assigned Patent Deposit Designation (ATCC Deposit No.) PTA-11843.

Claims
  • 1. A plant grown from a Momordica species interhybrid seed having ATCC accession number PTA-11843 derived from a tetra-cross pollination of parent species Momordica charantia, Momordica balsamina and a native Ecuadoran Momordica species, the seed having a zebra-like striped appearance, wherein the plant grown from the Momordica species interhybrid seed has a faster growth rate than any of the parent species.
  • 2. Parts of a plant grown from a Momordica species interhybrid seed having ATCC accession number PTA-11843 derived from a tetra-cross pollination of parent species Momordica charantia, Momordica balsamina and a native Ecuadoran Momordica species.
  • 3. The parts of a plant according to claim 2, wherein the seed produces hybrid plants having a larger leaf size and a more rounded fruit than any one of the parent species.
  • 4. A method of making an extract derived from parts of a plant grown from a Momordica species interhybrid seed having ATCC accession number PTA-11843 derived from a tetra-cross pollination of parent species Momordica charantia, Momordica balsamina and a native Ecuadoran Momordica species, comprising extracting the plant parts with an extraction liquid selected from the group consisting of water, ethanol, and mixtures thereof to provide an extract, the extract having blood glucose regulating properties, insulin regulating properties or a combination thereof.
  • 5. The method according to claim 4, further comprising combining the extract with an edible component.
  • 6. The method according to claim 5, wherein the extract combined with the edible component is a dietary supplement ingestible by an individual to maintain blood glucose levels at a normal level or to reduce blood glucose levels.
  • 7. The method according to claim 4, further comprising combining the extract with at least one beverage component.
  • 8. The method of claim 7, wherein the at least one beverage component comprises: a carbohydrate source;an amino acid blend;a pyruvate blend;a mineral blend;one or more vitamins; andone or more electrolytes.
Parent Case Info

This application claims the benefit of earlier filed U.S. Patent Application Ser. No. 60/972,165 filed on 13 Sep. 2007.

US Referenced Citations (54)
Number Name Date Kind
4084010 Takemoto et al. Apr 1978 A
4368149 Masuho et al. Jan 1983 A
5433965 Fischer et al. Jul 1995 A
5476998 Kataoka et al. Dec 1995 A
5484889 Lee-Huang et al. Jan 1996 A
5516535 Heckert et al. May 1996 A
5851531 Lazarus Dec 1998 A
5900240 Tomer et al. May 1999 A
5929047 Nakano Jul 1999 A
5942233 Chang Aug 1999 A
6103240 Zhou Aug 2000 A
6183747 Ren Feb 2001 B1
6210738 Chen Apr 2001 B1
6235286 Lazarus May 2001 B1
6379718 Ren Apr 2002 B2
6416806 Zhou Jul 2002 B1
6562379 Lazarus May 2003 B2
6682766 Blumenstein-Stahl et al. Jan 2004 B2
6770585 Vuong Aug 2004 B2
6800726 Rao et al. Oct 2004 B1
6831162 Khanna Dec 2004 B2
6960348 Rucker Nov 2005 B2
6964786 Khanna Nov 2005 B1
6986906 Selzer et al. Jan 2006 B2
7014872 Pushpangadan et al. Mar 2006 B2
7153529 Lazarus Dec 2006 B2
7160565 Rifkin Jan 2007 B2
7205010 Sha Apr 2007 B2
7238377 Piccirilli et al. Jul 2007 B2
20020187232 Lee et al. Dec 2002 A1
20030082168 Yegorova May 2003 A1
20030165603 Burklow et al. Sep 2003 A1
20030170365 Huang Sep 2003 A1
20040058050 Guo Mar 2004 A1
20040115329 Tamiya et al. Jun 2004 A1
20050118324 Mathew et al. Jun 2005 A1
20050152997 Selzer et al. Jul 2005 A1
20060003053 Ekanayake et al. Jan 2006 A1
20060040003 Needleman et al. Feb 2006 A1
20060093685 Mower et al. May 2006 A1
20060093686 Yoshitome et al. May 2006 A1
20060147561 Pushpangadan et al. Jul 2006 A1
20060172020 Djang Aug 2006 A1
20060189566 Komatsu et al. Aug 2006 A1
20060210688 Mower Sep 2006 A1
20060286259 Hargreaves Dec 2006 A1
20070020358 Mower Jan 2007 A1
20070059422 Robbins Mar 2007 A1
20070082075 Xu Apr 2007 A1
20070092623 Shimizu et al. Apr 2007 A1
20070098867 Singer May 2007 A1
20070110850 Rifkin May 2007 A1
20070122496 Managoli May 2007 A1
20070148186 Ketzis Jun 2007 A1
Foreign Referenced Citations (12)
Number Date Country
60-126074 Jul 1985 JP
08-168354 Jul 1996 JP
10-108654 Apr 1998 JP
2000-004852 Jan 2000 JP
2001-095541 Apr 2001 JP
2001-245640 Sep 2001 JP
2006-069948 Mar 2006 JP
9206106 Apr 1992 WO
9856396 Dec 1998 WO
WO 2005009351 Feb 2005 WO
2005076750 Aug 2005 WO
2007073096 Jun 2007 WO
Provisional Applications (1)
Number Date Country
60972165 Sep 2007 US